Bain Capital Life Sciences Investors, LLC Olema Pharmaceuticals, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $370 Million
- Q4 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 7,470,214 shares of OLMA stock, worth $36.1 Million. This represents 11.76% of its overall portfolio holdings.
Number of Shares
7,470,214Holding current value
$36.1 Million% of portfolio
11.76%Shares
1 transactions
Others Institutions Holding OLMA
# of Institutions
162Shares Held
71.9MCall Options Held
251KPut Options Held
6.7K-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$35.3 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$27.6 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$17.7 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16.6 Million0.88% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $195M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...